Anti-tTg-IgA is neither a Solved Problem nor a “closed case” in Celiac Disease Diagnosis
Journal: International Journal of Celiac Disease (Vol.5, No. 3)Publication Date: 2017-09-04
Authors : Aaron Lerner Sandra Neidhöfer Torsten Matthias;
Page : 97-100
Keywords : celiac disease; antibody; diagnosis; tissue transglutaminase; neo-epitope; microbial transglutaminase;
Abstract
Anti-tissue transglutaminase (tTg) IgA are considered the most frequently used serological marker for celiac disease diagnosis. Despite its recommended leading position by the 2012 ESPGHAN diagnostic criteria, it exposes multiple false positive and negative titers. In view of the critical opinions expressed lately in the literature against the application of those criteria, the bias in the central place occupied by tTg-IgA in the new ESPGHAN CD Diagnostic Guidelines and the emergence of newer serological marker for celiac disease, it is hoped that the revised guidelines will open up the limited, problematic and single Tg2-IgA antibody for other or additional single or combined serological diagnostic markers.
Other Latest Articles
- Deamidated Gliadin Peptide Antibodies; is the Time to Use as a Routine Test for Celiac Disease
- Celiac Disease: The Evolutionary Paradox
- A computational study and meta-analysis of content based image retrieval
- Heart beat peak detection using signal filtering in ECG data
- Machining optimization of composite material by using response surface methodology
Last modified: 2019-04-14 20:24:11